Laboratory Diagnostics

Companion diagnostics are revolutionizing pharmaceutical development and treatment, particularly in oncology. By identifying patients with specific biomarkers or disease-specific therapeutic targets, companion diagnostics significantly improve clinical success rates and patient outcomes. They also reduce costs by pinpointing the patient population most likely to benefit from a therapy and excluding those for whom the therapy would…

Description:

The past few years have seen extraordinary advances in artificial intelligence (AI) in clinical medicine. More products have been cleared for clinical use, more new research-use-only applications have come to market, and many more are in development. In recent years, diagnostics companies, in collaboration with AI companies, have begun implementing increasingly sophisticated machine learning…

This report provides an insightful update on the global in vitro diagnostics (IVD) market, analyzing various factors shaping its current landscape. Covering a span from 2019 to 2024, key topics include:

• Market Developments in Key Regions: North America, EU15/Western Europe, Eastern Europe, Japan, and China
• Examination of Genetic Testing Trends
• Insights into New Point-of-Care…

HbA1c testing has become a critical component in the detection and monitoring of diabetes, leading to a highly competitive and rapidly growing market within the in vitro diagnostics (IVD) industry. With increasing global expenditures on both professional and self-testing HbA1c assays, the market is flourishing. Over a dozen companies are actively producing analyzers, reagents, workstations,…

Biomarkers are biological or biochemical molecules, genetic changes, or other measurable characteristics that indicate or predict a condition, risk, or likely biological response. They have a wide range of diagnostic applications, including predicting disease risk, diagnosis, prognosis, identifying appropriate therapy, and monitoring disease or its recurrence.

Kalorama Information’s World Market for Biomarkers (Cardiac [cTn, HscTn,…

Description:

Unlock Key Insights into Customer Perceptions in Clinical Diagnostics

Understanding the Clinical Diagnostics Customer Experience: Results of the 2019 Kalorama Survey of Laboratories delves into the customer experience within the clinical diagnostics industry, offering an invaluable tool for understanding how your brand is perceived by your customers. As customer experience becomes a crucial differentiator…

In vitro diagnostic (IVD) products continue to experience robust sales growth across various categories, driven by new product innovations, global health spending shifts, regulatory changes, and evolving disease trends. In this dynamic market, companies are strategically acquiring new assets to enhance their revenue streams and foster product innovation. Kalorama Information’s latest report, Mergers and Acquisitions…

In the healthcare system, reducing costs, saving sample volume, cutting down provider time, and improving outcomes are crucial goals. Syndromic multiplex diagnostic panels are emerging as a key solution to meet these objectives. These innovative tests can identify multiple pathogens from a single clinical specimen, transforming diagnostics by enabling faster, more accurate patient management, infection…

Sexually transmitted diseases (STDs) present a significant public health challenge, with approximately 550 million new cases worldwide each year, including over 35 million in the US alone. Kalorama Information’s latest report, Sexually Transmitted Disease (STD) Testing Markets (Test Services, Diagnostics), offers an in-depth analysis of the global market for STD testing services and diagnostics from…